Single-cell transcriptomics reveals hair growth retardation mediated by aberrant connective tissue sheath contraction in male androgenetic alopecia. [PDF]
Li G +18 more
europepmc +1 more source
Exploring the mechanism of Platycladi Cacumen in intervening androgenetic alopecia based on network pharmacology, molecular docking, and molecular dynamics simulation. [PDF]
Liu J, Mei H, Ren C, Ma Y.
europepmc +1 more source
The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study. [PDF]
Lee CY +6 more
europepmc +1 more source
Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis. [PDF]
Hanelin DG, Amar S, Agalliu I.
europepmc +1 more source
Androgenetic Alopecia Is Not Associated with Increased Incidence of Cardiovascular Disease Risk Factors: A Retrospective Cohort Study. [PDF]
Benandi K +4 more
europepmc +1 more source
Quercetin Nanocrystal Gel: A Novel Topical Therapeutic Strategy for Androgenetic Alopecia. [PDF]
Su Y +7 more
europepmc +1 more source
Correction to 'Retinoic acid drives hair follicle stem cell activation via Wnt/β-catenin signalling in androgenetic alopecia'. [PDF]
europepmc +1 more source
Related searches:
Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50% of the male population. AGA is an androgen-related condition in genetically predisposed individuals. There is no treatment to completely reverse AGA in advanced stages, but with medical treatment (eg, finasteride, minoxidil, or a combination of both), the progression can ...
Nina, Otberg +2 more
+5 more sources
No abstract ...
Tosti A., Piraccini B. M.
openaire +3 more sources

